250 related articles for article (PubMed ID: 2972387)
1. Interleukin-1-independent activation of human T lymphocytes stimulated by anti-CD3 and a Hodgkin's disease cell line with accessory cell activity.
Ellis TM; McMannis JD; Chua AO; Gubler U; Fisher RI
Cell Immunol; 1988 Oct; 116(2):352-66. PubMed ID: 2972387
[TBL] [Abstract][Full Text] [Related]
2. Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responses.
Fisher RI; Bates SE; Bostick-Bruton F; Tuteja N; Diehl V
J Immunol; 1984 May; 132(5):2672-7. PubMed ID: 6609204
[TBL] [Abstract][Full Text] [Related]
3. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens.
Baroja ML; Lorre K; Van Vaeck F; Ceuppens JL
Cell Immunol; 1989 Apr; 120(1):205-17. PubMed ID: 2539266
[TBL] [Abstract][Full Text] [Related]
4. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
Kunicka JE; Platsoucas CD
Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
[TBL] [Abstract][Full Text] [Related]
5. Antigen presentation by Hodgkin's disease cells.
Fisher RI; Cossman J; Diehl V; Volkman DJ
J Immunol; 1985 Nov; 135(5):3568-71. PubMed ID: 3876389
[TBL] [Abstract][Full Text] [Related]
6. Activation of cord T lymphocytes. II. Cellular and molecular analysis of the defective response induced by anti-CD3 monoclonal antibody.
Bertotto A; Gerli R; Lanfrancone L; Crupi S; Arcangeli C; Cernetti C; Spinozzi F; Rambotti P
Cell Immunol; 1990 May; 127(2):247-59. PubMed ID: 2139363
[TBL] [Abstract][Full Text] [Related]
7. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
Verwilghen J; Baroja ML; Van Vaeck F; Van Damme J; Ceuppens JL
Immunology; 1991 Feb; 72(2):269-76. PubMed ID: 1826671
[TBL] [Abstract][Full Text] [Related]
8. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
[TBL] [Abstract][Full Text] [Related]
9. Monocyte-independent interleukin-2 production and proliferation of human T cells in response to murine hybridomas expressing the OKT3 monoclonal antibody: interleukin-1 is not required for T-cell proliferation.
Itoh K; Balch CM; Platsoucas CD
Cell Immunol; 1988 Aug; 115(1):36-56. PubMed ID: 2969776
[TBL] [Abstract][Full Text] [Related]
10. CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.
Pohl C; Denfeld R; Renner C; Jung W; Bohlen H; Sahin U; Hombach A; van Lier R; Schwonzen M; Diehl V
Int J Cancer; 1993 Jul; 54(5):820-7. PubMed ID: 7686889
[TBL] [Abstract][Full Text] [Related]
11. Requirement for delivery of signals by physical interaction and soluble factors from accessory cells in the induction of receptor-mediated T cell proliferation. Effectiveness of IFN-gamma modulation of accessory cells for physical interaction with T cells.
Kawakami K; Yamamoto Y; Kakimoto K; Onoue K
J Immunol; 1989 Mar; 142(6):1818-25. PubMed ID: 2493498
[TBL] [Abstract][Full Text] [Related]
12. Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex.
Massaia M; Bianchi A; Attisano C; Peola S; Redoglia V; Dianzani U; Pileri A
Blood; 1991 Oct; 78(7):1770-80. PubMed ID: 1832993
[TBL] [Abstract][Full Text] [Related]
13. Mitogenic activity of anti-CD28 MoAb CLB-CD28/1 on peripheral blood mononuclear cells and its cooperation with other anti-T cells MoAb in the activation of purified T lymphocytes.
De Felice M; Giarrusso PC; Lamberti A; Turco MC; Valerio G; van Lier RA; Yang SY; Ferrone S; Venuta S
Tissue Antigens; 1990 Jul; 36(1):12-8. PubMed ID: 1701062
[TBL] [Abstract][Full Text] [Related]
14. Growth factor production and requirements during the proliferative response of human T lymphocytes to anti-CD3 monoclonal antibody.
Granelli-Piperno A; Keane M; Steinman RM
J Immunol; 1989 Jun; 142(12):4138-43. PubMed ID: 2524526
[TBL] [Abstract][Full Text] [Related]
15. T cell activation induced by anti-CD3 antibodies requires prolonged stimulation of protein kinase C.
Davis LS; Lipsky PE
Cell Immunol; 1989 Jan; 118(1):208-21. PubMed ID: 2521304
[TBL] [Abstract][Full Text] [Related]
16. Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures.
Fisher RI; Bostick-Bruton F; Sauder DN; Scala G; Diehl V
J Immunol; 1983 Jun; 130(6):2666-70. PubMed ID: 6222113
[TBL] [Abstract][Full Text] [Related]
17. Evidence for IL-2 independent proliferation in human T cells.
Laing TJ; Weiss A
J Immunol; 1988 Feb; 140(4):1056-62. PubMed ID: 2830333
[TBL] [Abstract][Full Text] [Related]
18. Induction of human monocyte IL-1 mRNA and secretion during anti-CD3 mitogenesis requires two distinct T cell-derived signals.
Landis RC; Friedman ML; Fisher RI; Ellis TM
J Immunol; 1991 Jan; 146(1):128-35. PubMed ID: 1824588
[TBL] [Abstract][Full Text] [Related]
19. Modulatory effect of aggregating the CD3 molecular complex on T cell activation.
Gur H; Wacholtz MC; Davis LS; Geppert TD; Lipsky PE
Cell Immunol; 1992 Mar; 140(1):81-96. PubMed ID: 1531456
[TBL] [Abstract][Full Text] [Related]
20. Induction of interleukin 2 receptiveness and proliferation in resting peripheral T cells by monoclonal anti-CD3 (T3) antibodies does not require the presence of macrophages.
Stingl LA; Sinska A; Landesmann U; Smolen JS
Clin Exp Immunol; 1987 Apr; 68(1):146-55. PubMed ID: 3115639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
